Given financial constraints, it would be unethical to divert antiretroviral drugs from treatment to prevention.
about
Social justice and HIV vaccine research in the age of pre-exposure prophylaxis and treatment as preventionA scoping study to identify opportunities to advance the ethical implementation and scale-up of HIV treatment as prevention: priorities for empirical researchBioethical challenges with HIV treatment as preventionPartner notification in the context of HIV: an interest-analysis.Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and advocacy for access.Ethical use of antiretroviral resources for HIV prevention in resource poor settings.Efficient single tobamoviral vector-based bioproduction of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 in Nicotiana benthamiana plants and utility of VRC01 in combination microbicidesEthics and pre-exposure prophylaxis for HIV infection.Balancing efficiency, equity and feasibility of HIV treatment in South Africa - development of programmatic guidance.Separate goals, converging priorities: on the ethics of treatment as prevention.PrEP Implementation Science: State-of-the-Art and Research Agenda.Anti-retrovirals for treatment and prevention--time for new paradigms in our response to the HIV/AIDS epidemic?Untangling the cost-effectiveness knot: who is oral antiretroviral HIV pre-exposure prophylaxis really for?
P2860
Q33854562-97843F28-E70F-4FFF-B6DE-4D15D6DE54D5Q33861390-32DCF218-FE8D-4241-9F8B-E77507B40682Q34077711-5FEBB832-E3D6-4A4C-BE57-1F314F01E953Q35568664-5EEE6DD4-0DFC-495F-BEB5-B0D9840FD2FCQ35875746-C368A87D-E84D-4BBA-BB30-AE5464736DD8Q36377733-55BB6479-B133-484B-A844-DBD9FD2C2000Q36785795-C446D22B-A062-47A8-907E-773C0568BB03Q37058067-EAC8032C-2F70-4D8E-A2A0-C538E6FC343BQ37365039-1A92AF7A-638E-4FCE-A100-F076F66413CCQ42257530-C7DFCEB5-8816-4056-A4BD-C6FFA8A0561BQ43241737-0B0B616C-9690-4DA4-8A2A-3E61554806DEQ43715712-53E60DCA-57B1-4DEF-97D4-E55718BA69C6Q47797591-5D8382B7-273D-4B60-89D5-108FFEA57548
P2860
Given financial constraints, it would be unethical to divert antiretroviral drugs from treatment to prevention.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Given financial constraints, i ...... from treatment to prevention.
@ast
Given financial constraints, i ...... from treatment to prevention.
@en
type
label
Given financial constraints, i ...... from treatment to prevention.
@ast
Given financial constraints, i ...... from treatment to prevention.
@en
prefLabel
Given financial constraints, i ...... from treatment to prevention.
@ast
Given financial constraints, i ...... from treatment to prevention.
@en
P2860
P1433
P1476
Given financial constraints, i ...... from treatment to prevention.
@en
P2093
Ethan Cowan
Ruth Macklin
P2860
P304
P356
10.1377/HLTHAFF.2012.0071
P407
P577
2012-07-01T00:00:00Z